Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Onlangs maakte Novo Nordisk, de Deense fabrikant van semaglutide, uitkomsten bekend uit de fase-3 OASIS-I studie met hooggedoseerd semaglutide in tabletvorm, waarbij mensen gemiddeld 15% van hun lichaamsgewicht kwijtraakten
Whether patients haven't yet reached their weight loss goals on lower-dose Wegovy injectables, or they simply have a more significant amount of weight to lose, the 21% weight loss demonstrated in the STEP UP trial, if all patients stayed on treatment, shows what's possible with this new dose, and that's an opportunity we're excited to provide," said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk
How long will I have to take GLP-1 weight loss injections
A comparative analysis reveals tirzepatides superior performance in weight loss and glycemic control, but when it comes to safety, the tapestry is more nuanced
US$ 22.88
US$ 28.72
US$ 24.07
US$ 25.84
US$ 25.86
